The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System DOI Open Access
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(18), P. 10028 - 10028

Published: Sept. 17, 2021

The gut microbiome has attracted increasing attention from researchers in recent years. microbiota can have a specific and complex cross-talk with the host, particularly central nervous system (CNS), creating so-called “gut–brain axis”. Communication between gut, intestinal microbiota, brain involves secretion of various metabolites such as short-chain fatty acids (SCFAs), structural components bacteria, signaling molecules. Moreover, an imbalance composition modulates immune function tissue barriers blood–brain barrier (BBB). Therefore, aim this literature review is to describe how gut–brain interplay may contribute development neurological disorders, combining fields gastroenterology neuroscience. We present findings concerning effect altered on neurodegeneration neuroinflammation, including Alzheimer’s Parkinson’s diseases, well multiple sclerosis. impact pathological shift selected neuropsychological i.e., major depressive disorders (MDD) autism spectrum disorder (ASD), also discussed. Future research balanced axis would help identify new potential opportunities for therapeutic interventions presented diseases.

Language: Английский

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment DOI Creative Commons
Shan Liu,

Jiguo Gao,

Mingqin Zhu

et al.

Molecular Neurobiology, Journal Year: 2020, Volume and Issue: 57(12), P. 5026 - 5043

Published: Aug. 22, 2020

Understanding how gut flora influences gut-brain communications has been the subject of significant research over past decade. The broadening term "microbiota-gut-brain axis" from "gut-brain underscores a bidirectional communication system between and brain. microbiota-gut-brain axis involves metabolic, endocrine, neural, immune pathways which are crucial for maintenance brain homeostasis. Alterations in composition microbiota associated with multiple neuropsychiatric disorders. Although causal relationship dysbiosis neural dysfunction remains elusive, emerging evidence indicates that may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, insulin resistance pathogenesis Alzheimer's disease (AD). Illustration mechanisms underlying regulation by pave way developing novel therapeutic strategies AD. In this narrative review, we provide an overview their dysregulation Novel insights into modification as preventive or approach AD highlighted.

Language: Английский

Citations

335

Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions DOI Open Access

Suganya Kanmani,

Byung‐Soo Koo

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 21(20), P. 7551 - 7551

Published: Oct. 13, 2020

The gut microbiome acts as an integral part of the gastrointestinal tract (GIT) that has largest and vulnerable surface with desirable features to observe foods, nutrients, environmental factors, well differentiate commensals, invading pathogens, others. It is well-known a strong connection central nervous system (CNS) in context health disease. A healthy diverse microbes vital for normal brain functions emotional behaviors. In addition, CNS controls most aspects GI physiology. molecular interaction between gut/microbiome complex bidirectional, ensuring maintenance homeostasis proper digestion. Besides this, several mechanisms have been proposed, including endocrine, neuronal, toll-like receptor, metabolites-dependent pathways. Changes bidirectional relationship GIT are linked pathogenesis neurological disorders; therefore, microbiota/gut-and-brain axis emerging widely accepted concept. this review, we summarize recent findings supporting role microbiota immune on development disorders. highlight advances improving diseases by probiotics/prebiotics/synbiotics fecal transplantation via concept gut–brain axis.

Language: Английский

Citations

244

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases DOI Creative Commons
Jian Sheng Loh, Wen Qi Mak, Li Tan

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Feb. 16, 2024

Abstract The human gastrointestinal tract is populated with a diverse microbial community. vast genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every aspect biology, including health maintenance, development, aging, disease. advent new sequencing technologies culture-independent methods has allowed researchers to move beyond correlative studies toward mechanistic explorations shed light on microbiome–host interactions. Evidence unveiled bidirectional communication between central nervous system, referred as “microbiota–gut–brain axis”. microbiota–gut–brain axis represents an important regulator glial functions, making it actionable target ameliorate development progression neurodegenerative diseases. In this review, we discuss mechanisms As provides essential cues microglia, astrocytes, oligodendrocytes, examine communications microbiota these cells during healthy states Subsequently, diseases using metabolite-centric approach, while also examining role microbiota-related neurotransmitters hormones. Next, targeting intestinal barrier, blood–brain meninges, peripheral immune system counteract dysfunction neurodegeneration. Finally, conclude by assessing pre-clinical clinical evidence probiotics, prebiotics, fecal transplantation A thorough comprehension will foster effective therapeutic interventions for management

Language: Английский

Citations

231

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame? DOI Open Access
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė

et al.

Nutrients, Journal Year: 2020, Volume and Issue: 13(1), P. 37 - 37

Published: Dec. 24, 2020

For years, it has been reported that Alzheimer’s disease (AD) is the most common cause of dementia. Various external and internal factors may contribute to early onset AD. This review highlights a contribution disturbances in microbiota–gut–brain (MGB) axis development Alteration gut microbiota composition determined by increase permeability barrier immune cell activation, leading impairment blood–brain function promotes neuroinflammation, neuronal loss, neural injury, ultimately Numerous studies have shown plays crucial role brain changes behavior individuals formation bacterial amyloids. Lipopolysaccharides amyloids synthesized can trigger cells residing activate response neuroinflammation. Growing experimental clinical data indicate prominent dysbiosis microbiota–host interactions Modulation with antibiotics or probiotic supplementation create new preventive therapeutic options Accumulating evidences affirm research on MGB involvement AD necessary for treatment targets therapies

Language: Английский

Citations

227

Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1 DOI Creative Commons
Na Kong, Xiaying Chen, Jiao Feng

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2021, Volume and Issue: 11(12), P. 4045 - 4054

Published: March 27, 2021

Ferroptosis is a non-apoptotic regulated cell death caused by iron accumulation and subsequent lipid peroxidation. Currently, the therapeutic role of ferroptosis on cancer gaining increasing interest. Baicalin an active component in

Language: Английский

Citations

188

Sources, formulations, advanced delivery and health benefits of probiotics DOI

Ume Roobab,

Zahra Batool, Muhammad Faisal Manzoor

et al.

Current Opinion in Food Science, Journal Year: 2020, Volume and Issue: 32, P. 17 - 28

Published: Jan. 18, 2020

Language: Английский

Citations

165

Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice DOI

Namkwon Kim,

Seung Ho Jeon, In Gyoung Ju

et al.

Brain Behavior and Immunity, Journal Year: 2021, Volume and Issue: 98, P. 357 - 365

Published: Sept. 6, 2021

Language: Английский

Citations

159

Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota DOI
Xiaohang Qian,

Xiaoxuan Song,

Xiaoli Liu

et al.

Ageing Research Reviews, Journal Year: 2021, Volume and Issue: 68, P. 101317 - 101317

Published: March 10, 2021

Language: Английский

Citations

119

The intestinal barrier in disorders of the central nervous system DOI
Carolina Pellegrini, Matteo Fornai, Vanessa D’Antongiovanni

et al.

˜The œLancet. Gastroenterology & hepatology, Journal Year: 2022, Volume and Issue: 8(1), P. 66 - 80

Published: Nov. 2, 2022

Language: Английский

Citations

115

Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease DOI Creative Commons
Shaochang Wu, Xia Liu,

Ruilai Jiang

et al.

Frontiers in Aging Neuroscience, Journal Year: 2021, Volume and Issue: 13

Published: May 28, 2021

Alzheimer's disease (AD) is the most common age-related progressive neurodegenerative disease, characterized by a decline in cognitive function and neuronal loss, caused several factors. Numerous clinical experimental studies have suggested involvement of gut microbiota dysbiosis patients with AD. The altered can influence brain behavior through microbiota-gut-brain axis via various pathways such as increased amyloid-β deposits tau phosphorylation, neuroinflammation, metabolic dysfunctions, chronic oxidative stress. With no current effective therapy to cure AD, modulation may be promising therapeutic option prevent or delay onset AD counteract its progression. Our present review summarizes alterations pathogenetic roles mechanisms microbiota-targeted therapies for Understanding between will help decipher pathogenesis from novel perspectives shed light on strategies

Language: Английский

Citations

106